• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Pascal Soriot

Pascal Soriot AstraZeneca CEO
Pharma

AZ CEO Pascal Soriot talks global 'rebalancing of pricing'

The longtime CEO said the company has had many talks with the U.S. government and has proposed price reduction plans for its drugs.
Zoey Becker Jul 29, 2025 2:00pm
Pascal Soriot

AZ reveals plan for huge site in Virginia, part of $50B US outlay

Jul 22, 2025 7:45am
Pascal Soriot AstraZeneca CEO

Soriot plots move of AZ stock listing to US: The Times

Jul 2, 2025 11:10am
Pay CEO pay pay rankings

The 10 highest-paid Big Pharma CEOs of 2024

Jun 16, 2025 3:00am
Pascal Soriot

AZ slashes CEO Pascal Soriot's pay by 16% to $18.5M in 2024

Feb 19, 2025 8:20am
AZ

AstraZeneca logs China sales decline in Q4 amid probes

Feb 6, 2025 10:31am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings